U.S. Hospitals Are Running Out Of A Crucial Covid Drug Amid Delta Surge And Worldwide Shortages

Hospitals could be without tocilizumab, one of the only therapies for Covid-19 patients cleared for use in the U.S., for weeks and the World Health Organization urged maker Roche to ensure it is distributed fairly around the world.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Policy /policy Manufacturing /manufacturing Breaking breaking-news Editors' Pick editors-pick Coronavirus Source Type: news